126 related articles for article (PubMed ID: 11216701)
1. Secondary acute myelogenous leukemia in patients previously treated for childhood renal tumors: a report from the National Wilms Tumor Study Group.
Shearer P; Kapoor G; Beckwith JB; Takashima J; Breslow N; Green DM
J Pediatr Hematol Oncol; 2001 Feb; 23(2):109-11. PubMed ID: 11216701
[TBL] [Abstract][Full Text] [Related]
2. Bilateral Wilms' tumors: single-center experience with 22 cases and literature review.
Sarhan OM; El-Baz M; Sarhan MM; Ghali AM; Ghoneim MA
Urology; 2010 Oct; 76(4):946-51. PubMed ID: 20708784
[TBL] [Abstract][Full Text] [Related]
3. Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation.
Kröger N; Zander AR; Martinelli G; Ferrante P; Moraleda JM; Da Prada GA; Demirer T; Socie G; Rosti G;
Ann Oncol; 2003 Apr; 14(4):554-8. PubMed ID: 12649100
[TBL] [Abstract][Full Text] [Related]
4. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
[TBL] [Abstract][Full Text] [Related]
5. Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have common risk factors?
Pagano L; Pulsoni A; Tosti ME; Mele A; Mele L; Corvatta L; Miraglia E; Almici C; Manna A; Del Poeta G; Lanza F; Masini L; Recchia A; Equitani F; Leone G; Mandelli F;
Hematol J; 2000; 1(5):329-32. PubMed ID: 11920210
[TBL] [Abstract][Full Text] [Related]
6. Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group.
Breslow NE; Takashima JR; Whitton JA; Moksness J; D'Angio GJ; Green DM
J Clin Oncol; 1995 Aug; 13(8):1851-9. PubMed ID: 7636528
[TBL] [Abstract][Full Text] [Related]
7. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Danish Society of Haematology Study Group on AML.
de Nully Brown P; Hoffmann T; Hansen OP; Boesen AM; Grønbaek K; Hippe E; Jensen MK; Thorling K; Storm HH; Pedersen-Bjergaard J
Leukemia; 1997 Jan; 11(1):37-41. PubMed ID: 9001416
[TBL] [Abstract][Full Text] [Related]
9. Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group.
Feusner JH; Ritchey ML; Norkool PA; Takashima JR; Breslow NE; Green DM
Pediatr Blood Cancer; 2008 Feb; 50(2):242-5. PubMed ID: 17458877
[TBL] [Abstract][Full Text] [Related]
10. Synchronous bilateral Wilm's tumor with complete radiographic response managed without surgical resection: a report from the National Wilm's Tumor Study 4.
Hamilton TE; Ritchey ML; Argani P; Beckwith JB; Perlman EJ; Cotton CA; Shamberger RC
J Pediatr Surg; 2008 Nov; 43(11):1982-4. PubMed ID: 18970928
[TBL] [Abstract][Full Text] [Related]
11. The incidence of secondary leukemias.
Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
[TBL] [Abstract][Full Text] [Related]
12. Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials.
Pagano L; Pulsoni A; Vignetti M; Tosti ME; Falcucci P; Fazi P; Fianchi L; Levis A; Bosi A; Angelucci E; Bregni M; Gabbas A; Peta A; Coser P; Ricciuti F; Morselli M; Caira M; Foà R; Amadori S; Mandelli F; Leone G;
Ann Oncol; 2005 Feb; 16(2):228-33. PubMed ID: 15668275
[TBL] [Abstract][Full Text] [Related]
13. Secondary neoplasms after Wilms' tumor in Germany.
Nourkami N; Furtwängler R; Alkassar M; Graf N;
Strahlenther Onkol; 2009 Aug; 185 Suppl 2():11-2. PubMed ID: 19685027
[No Abstract] [Full Text] [Related]
14. Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia.
Rodrigues PC; Oliveira SN; Viana MB; Matsuda EI; Nowill AE; Brandalise SR; Yunes JA
Pediatr Blood Cancer; 2007 Aug; 49(2):133-8. PubMed ID: 16883592
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia as a second malignancy: report of 9 pediatric patients in a single institution in Argentina.
Felice MS; Zubizarreta PA; Chantada GL; Alfaro E; Cygler AM; Gallego M; Rossi J; Sackmann-Muriel F
Med Pediatr Oncol; 1998 Mar; 30(3):160-4. PubMed ID: 9434824
[TBL] [Abstract][Full Text] [Related]
16. Acute myelogenous leukemia after treatment for malignant germ cell tumors in children.
Schneider DT; Hilgenfeld E; Schwabe D; Behnisch W; Zoubek A; Wessalowski R; Göbel U
J Clin Oncol; 1999 Oct; 17(10):3226-33. PubMed ID: 10506623
[TBL] [Abstract][Full Text] [Related]
17. Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients.
Colovic M; Colovic N; Radojkovic M; Stanisavljevic D; Kraguljac N; Jankovic G; Tomin D; Suvajdzic N; Vidovic A; Atkinson HD
Ann Hematol; 2012 Sep; 91(9):1363-70. PubMed ID: 22592651
[TBL] [Abstract][Full Text] [Related]
18. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
Haase D; Hanf V; Schulz T
Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
[TBL] [Abstract][Full Text] [Related]
19. Second primary neoplasms in survivors of Wilms' tumour--a population-based cohort study from the British Childhood Cancer Survivor Study.
Taylor AJ; Winter DL; Pritchard-Jones K; Stiller CA; Frobisher C; Lancashire ER; Reulen RC; Hawkins MM;
Int J Cancer; 2008 May; 122(9):2085-93. PubMed ID: 18196579
[TBL] [Abstract][Full Text] [Related]
20. Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group.
Lenz G; Dreyling M; Schiegnitz E; Haferlach T; Hasford J; Unterhalt M; Hiddemann W
J Clin Oncol; 2004 Dec; 22(24):4926-33. PubMed ID: 15611507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
